Your search for

124 results were returned

  1. Legal news
    31 October 2018
    Talking Shop October 2018
    www.twobirds.com/en/news/articles/2018/global/talking-shop-october-2018

    This newsletter focuses on key news and updates for retail and consumer-facing businesses around the world.

  2. Legal news
    30 September 2018
    Talking Shop September 2018
    www.twobirds.com/en/news/articles/2018/global/talking-shop-september-2018

    This newsletter focuses on key news and updates for retail and consumer-facing businesses around the world.

  3. Legal news
    11 February 2020
    New German legislation allows access to the iPhone's NFC antenna
    www.twobirds.com/en/news/articles/2020/germany/new-german-legislation-allows-access-to-the-iphones-nfc-antenna

    As part of the implementation of the fifth Anti-Money Laundering Directive (AMLD5), the German Parliament has decided to require providers of technical infrastructures, such as Apple in relation to the Near Field ...

  4. Legal news
    14 July 2020
    The EU Court of Justice provides guidance for the antitrust assessment of "pay-for-delay" agreements in the pharmaceutical sector.
    www.twobirds.com/en/news/articles/2020/global/the-eu-court-of-justice-provides-guidance-for-the-antitrust

    The Court of Justice provided guidance for the antitrust assessment of agreements between competitors in the pharmaceutical sector. The Court's judgment is relevant because it addresses fundamental issues that have been ...

  5. Legal news
    17 March 2020
    Double Caution: Gun Jumping Risks in M&A Transactions
    www.twobirds.com/en/news/articles/2020/global/double-caution-gun-jumping-risks-in-m-and-a-transactions

    Following a few interesting EU developments regarding gun jumping in concentrations our Competition team looked into the relevance for M&A transactions, whilst taking into perspective what the ECJ and European ...

  6. Twobirds news
    15 April 2019
    Bird & Bird advises Infront ASA on acquisition of vwd Group from The Carlyle Group
    www.twobirds.com/en/news/press-releases/2019/germany/bird-bird-beraet-infront-asa-bei-der-uebernahme-der-vwd-group

    International law firm Bird & Bird is advising Norwegian company Infront ASA ('Infront') on its acquisition of German company vwd Group GmbH and its European subsidiaries. The current majority shareholder, US private ...

  7. Legal news
    22 November 2019
    Case notes: Landmark ruling of the Court of Justice of the European Union (CJEU) on validity of airport charges
    www.twobirds.com/en/news/articles/2019/global/case-notes-landmark-ruling-of-the-court-of-justice-of-the-european-union

    The Court of Justice of the European Union (CJEU) has rendered a landmark decision ruling that airports must not agree with individual airport users preferential airport charges different from those approved by the ...

  8. Legal news
    18 December 2019
    Large tech merger provides an early opportunity to test the fitness of the competition regime in 2020
    www.twobirds.com/en/news/articles/2019/global/large-tech-merger-provides-an-early-opportunity-to-test-the-fitness-of-the-competition

    Google's proposed acquisition of Fitbit provides an opportunity to test the fitness of the competition regime and reflect upon the ongoing global scrutiny of Big Tech.

  9. Legal news
    07 May 2020
    Slovakia & COVID-19 & Financial update
    www.twobirds.com/en/news/articles/2020/slovakia/slovakia-covid19-financial-update

    The COVID-19 pandemic is disrupting our daily lives, as well as entrepreneurs' operations in all business sectors. The state authorities must react fast and adopt legislation aiming at mitigating the COVID-19 negative ...

  10. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")